日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype

更正:天冬氨酸β-羟化酶表达促进胰腺恶性细胞表型

Dong, Xiaoqun; Lin, Qiushi; Aihara, Arihiro; Li, Yu; Huang, Chiung-Kuei; Chung, Waihong; Tang, Qi; Chen, Xuesong; Carlson, Rolf; Nadolny, Christina; Gabriel, Gregory; Olsen, Mark; Wands, Jack R

Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasm

胰腺神经内分泌肿瘤恶性潜能评估的宏观形态学

Katsuta, Eriko; Kudo, Atsushi; Akashi, Takumi; Mitsunori, Yusuke; Matsumura, Satoshi; Aihara, Arihiro; Ban, Daisuke; Ochiai, Takanori; Tanaka, Shinji; Eishi, Yoshinobu; Tanabe, Minoru

Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.

第二代β-羟化酶抑制剂对胆管癌发生发展中的抗肿瘤作用

Huang Chiung-Kuei, Iwagami Yoshifumi, Aihara Arihiro, Chung Waihong, de la Monte Suzanne, Thomas John-Michael, Olsen Mark, Carlson Rolf, Yu Tunan, Dong Xiaoqun, Wands Jack

A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma

细胞表面β-羟化酶是肝细胞癌的生物标志物和治疗靶点。

Aihara, Arihiro; Huang, Chiung-Kuei; Olsen, Mark J; Lin, Qiushi; Chung, Waihong; Tang, Qi; Dong, Xiaoqun; Wands, Jack R

Favorable response after gemcitabine-radiotherapy for invasive pancreatic intraductal papillary mucinous neoplasm: a case report

吉西他滨联合放疗治疗侵袭性胰腺导管内乳头状黏液性肿瘤后疗效良好:病例报告

Ochiai, Takanori; Igari, Kimihiro; Furuyama, Takaki; Ito, Hiromitsu; Mitsunori, Yusuke; Aihara, Arihiro; Kumagai, Yoichi; Iida, Michio; Odajima, Hajime; Tanaka, Shinji; Arii, Shigeki; Yamazaki, Shigeru

Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy

Villin 1 是肝切除术后高血清甲胎蛋白相关肝细胞癌复发的预测因子。

Xieraili, Maimaiti; Yasen, Mahmut; Mogushi, Kaoru; Obulhasim, Gulanbar; Mayinuer, Abudureheman; Aihara, Arihiro; Tanaka, Shinji; Mizushima, Hiroshi; Tanaka, Hiroshi; Arii, Shigeki

Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case

一例升结肠癌合并肺转移和43个肝转移灶的患者,采用根治性肝切除联合5-氟尿嘧啶/亚叶酸钙、奥沙利铂和贝伐珠单抗联合化疗,疗效显著:病例报告

Ochiai, Takanori; Masuda, Taiki; Yagi, Masayuki; Kasai, Reo; Furuyama, Takaki; Tsukamoto, Kanako; Ito, Hiromitsu; Igari, Kimihiro; Aihara, Arihiro; Kumagai, Yoichi; Iida, Michio; Odajima, Hajime; Tanaka, Shinji; Arii, Shigeki; Yamazaki, Shigeru